Massive funding that allowed us to scale up production. Every vaccine was being used. What we did was use a platform that has been around for over a decade, so we know it safe. We know its effective. I will get one as soon as they tell me that i can. Harris White House Press secretary Kayleigh Mcenany is here on this momentous day. First, the physical battle from the frontline. Professor of medicine at nyu Medical Center and fox news medical contributor, dr. Marc siegel is in new york. It all began with that Critical Care nurse today, getting the shot in her arm. Your concerns, your thoughts, your excitement on this day . All of it. Harris, it is a very exciting day in america on the covid front lines. Including here in new york when we fought some of the very big battles. As we speak, harris, the vaccine has been running into the rescue. You can see the vaccine arriving, but what happens, it needs to be though thawed out. Doctors, nurses, respiratory therapist, they will be the first
On facebook, youtube, twitter and from axios. Com. With theollow along axios on twitter. We will unpack how the pandemic has changed the trajectory of healthcare and what is expected over the next four years. Is dr. Robertt blendon, professor of Health Policy at the school of Public Health. He is joining us from boca raton. Welcome. Thank you for having me. Theets Start Talking about Number One Health topic right now, the coronavirus. Lets talk about equities and disparities. Can you outline what are the best things we can do from a policy perspective to help reduce the pain of the pandemic and to reduce the inequities associated over the next few months . Dr. Blendon first i want to be very cautious. A number of things are done under an emergency basis over the next six months. A lot of like and hispanic americans could die. There are a lot of things we can do about race inequity that are really important. I am really worried about the next six months. Americansent black and latino am
And we lead the program with the latest development in the treatment of copa 19 in the u. S. Food and Drug Administration on monday authorized emergency use of eli lillys experiment mental antibody treatment. Thats balm let me be mocked the f. D. A. Said the emergency use authorization was given based on Clinical Trials showing the drug reduced the need for hospitalization or emergency room visits and high risk tobit 1000 patients now the regulator added that it can be used now for treating patients over the age of 12 with mild to moderate symptoms but cannot be used for patients who have been hospitalized due to cope at 19 lilly is hoping to supply as many as 1000000 doses of the treatment in the 4th quarter of this year now the u. S. Government previously made an agreement with the drug maker for the early supply of the medication on the news lately stock was up as much as 4 percent throughout the day. And following the news that pfizer bio and texaco but 1000 vaccine candidate showe
Joe biden, to be president elect someone thats not words, final vote, determination. And we arent there yet once the election free and fair. And what is the possibility of the country election . And this is boom, bust of the one business show you cant afford to miss boring. Washington coming up. The developments in the field of cope with 900. 00 treatment continue to roll with the f. D. A. Has approved a major anybody treatment thats straight ahead plus markets are still on the move following positive vaccine news coming up, we analyzed the wave of stock stories and where this rally could lead, and later amazon is facing the hot seat in europe as the block has moved to open a new investigation into the ecommerce behemoth with a packed show today. So lets dive right in and we lead the program with the latest development in the treatment of copa 19 in the u. S. Food and Drug Administration on monday, authorized emergency use of eli lillys experiment, mental antibody treatment. Thats balm
But 19 vaccine candidate showed an efficacy of 90 percent. The European Commission will sign a deal to secure up to 300000000 doses of the experimental drug. The president of the European Commission said they will authorize the deal on wednesday after quote, working tirelessly to secure doses of a potential vaccine. In the last few months. German health minister, yes. On tuesday had confirmed the block was ready to secure at least 200000000 doses of pfizers drug adding. They had also made deals with other drug makers. With bio in tech, as announced yesterday. You Commission President this vanderlei and we will be able to bring the negotiations to a conclusion very quickly. In any case, the mention of at least 200000000 doses for the European Union is secured. Now it just has to be finally secured in the contract. And meanwhile, biotechs head of strategy, Ryan Richardson was asked about profiting from the development a drug that receives funding from the German Government during a Finan